Main reasons for stopping study treatment and side effects.
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
*participants without relevant follow-up data at 12 weeks (10 vs 9) were assumed to have stopped treatment in the definition of tolerability as the primary trial outcome, which was therefore 44 (23%) vs 33 (18%). **for patients discontinuing treatment, the total is a direct sum as data reflect the main reason for stopping for each patient. For patients not discontinuing treatment, the total refers to the number of people reporting one or more side effects.
创建时间：
2011-05-25
